Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2010 Jan 19;24(1):25–30. doi: 10.1002/jcla.20356

Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study

Nihayet Bayraktar 1, Suleyman Kilic 2, Mehmet Refik Bayraktar 3,✉, Nurten Aksoy 4
PMCID: PMC6647705  PMID: 20087949

Abstract

It is well known that antioxidants and reactive oxygen species play an important role in carcinogenesis. In this sudy, we attempted to evaluate antioxidant enzyme activities and lipid peroxidation levels in cancerous bladder tissue and to determine their relationship with bacterial infection. Bacterial culture was made from all urine samples using Blood and Eosin Methylene Blue agars for checking the presence of bacterial infections. We measured thiobarbituric acid reactive substances (TBARs) and activities of xanthine oxidase (XO), superoxide dismutase (SOD), glutathione peroxidase (GSH‐PX), and catalase (CAT) in cancerous tissues of 25 bladder cancer patients, in noncancerous adjacent bladder tissues of 13 out of these 25 patients, and in control bladder tissues of 15 patients with a non‐neoplastic genitourinary disease. TBARs levels increased and XO, SOD, GSH‐PX, and CAT activities decreased significantly in cancerous bladder tissues. TBARS, XO, and SOD levels were not significantly different between noncancerous adjacent tissue and control bladder tissue. Statistically significantly lower GSH‐PX and higher CAT activities were observed in noncancerous adjacent bladder tissue compared with cancerous tissue. GSH‐PX level of tumor tissue was correlated significantly with tumor grade (r=−0.425, P=0.034). Results suggested that pathway activity of free radicals were accelerated in the cancerous human bladder tissues via increased TBARs levels and decreased enzyme activities of XO, SOD, GSH‐PX, and CAT, which implicated a severe exposure of cancerous tissues to oxidative stress. J. Clin. Lab. Anal. 24:25–30, 2010. © 2010 Wiley‐Liss, Inc.

Keywords: bladder cancer, xanthine oxidase, superoxide dismutase, glutathione peroxidase, catalase, thiobarbituric acid reactive substances

REFERENCES

  • 1. Singh SV, Xu BH, Tkalcevic GT, Gupta V, Roberts B, Ruiz P. Glutathione‐linked detoxification pathway in normal and malignant human bladder tissue. Cancer Lett 1994;77:15–24. [DOI] [PubMed] [Google Scholar]
  • 2. Aruoma OI. Antioxidant action of plant foods: use of oxidative DNA damage as a tool for studying antioxidant efficacy. Free Radic Res 1999;30:419–427. [DOI] [PubMed] [Google Scholar]
  • 3. Zhan CD, Sindhu RK, Pang J, Ehdaie A, Vaziri ND. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant‐rich diet. J Hypertens 2004;22:2025–2033. [DOI] [PubMed] [Google Scholar]
  • 4. Camici M, Tozzi MG, Allegrini S. Purine salvage enzyme activity in normal and neoplastic human tissues. Cancer Biochem Biophys 1990;11:201–209. [PubMed] [Google Scholar]
  • 5. Anjaneyulu M, Tirkey N, Chopra K. Attenuation of cyclosporine‐induced renal dysfunction by catechin: possible antioxidant mechanism. Ren Fail 2003;25:691–707. [DOI] [PubMed] [Google Scholar]
  • 6. Bayraktar NM, Karagözler AA, Bayraktar M, Titrer S, Gözükara EM. Investigation of the blood biochemical status of gas station workers. Toxicol Environ Chem 2006;88:587–594. [Google Scholar]
  • 7. Batcioglu K, Mehmet N, Ozturk IC, et al. Lipid peroxidation and antioxidant status in stomach cancer. Cancer Investigation 2006;24:18–21. [DOI] [PubMed] [Google Scholar]
  • 8. Leyva F, Anker SD, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18:858–865. [DOI] [PubMed] [Google Scholar]
  • 9. Doehner W, Anker SD. Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure? Heart 2005;91:707–709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Bakhtiiarov ZA. Changes in xanthine oxidase activity in patients with circulatory failure. Ter Arkh 1989;61:68–69. [PubMed] [Google Scholar]
  • 11. Mehmet N, Refik M, Harputluoglu M, Ersoy Y, Aydin NE, Yildirim B. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori. New Microbiol 2004;27:139–148. [PubMed] [Google Scholar]
  • 12. Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin 2008;58:180–190. [DOI] [PubMed] [Google Scholar]
  • 13. Ichimura Y, Habuchi T, Tsuchiya N, et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant J Urol 2004;172:728–732. [DOI] [PubMed] [Google Scholar]
  • 14. Demirbilek S, Ersoy MO, Demirbilek S, et al. Effects of polyenylphosphatidylcholine on cytokines, nitrite/nitrate levels, antioxidant activity and lipid peroxidation in rats with sepsis. Intensive Care Med 2004;65:1974–1978. [DOI] [PubMed] [Google Scholar]
  • 15. Hashimato S. A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal Biochem 1974;62:425–435. [DOI] [PubMed] [Google Scholar]
  • 16. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497–500. [PubMed] [Google Scholar]
  • 17. Paglia DE, Valentine W. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158–169. [PubMed] [Google Scholar]
  • 18. Aebi H. Catalase In Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York: Academic Press; 1974. p 673–680. [Google Scholar]
  • 19. Lowry O, Rosebrough N, Farr L, Randall R. Protein measurement with folin phenol reagent. J Biol Chem 1951;182:265–275. [PubMed] [Google Scholar]
  • 20. Wasowich W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid‐reactive substances in serum: importance of extraction pH and influences of sample preservation and storage. Clin Chem 1992;39:2522–2526. [PubMed] [Google Scholar]
  • 21. Doehner W, Schoene N, Rauchhaus M, et al. The effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failur results from two placebo controlled studies. Circulation 2002;105:2619–2624. [DOI] [PubMed] [Google Scholar]
  • 22. Anker SD, Doehner W, Rauchhaus M. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991–1997. [DOI] [PubMed] [Google Scholar]
  • 23. Bagnati M, Perugini C, Cau C. When and why a water‐soluble antioxidant becomes pro‐oxidant during copper‐induced low‐density lipoprotein oxidation: a study using uric acid. Biochem J 1999;340:143–152. [PMC free article] [PubMed] [Google Scholar]
  • 24. Dahle LK, Hill EG, Hollman RT. The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys 1962;98:253–261. [DOI] [PubMed] [Google Scholar]
  • 25. Anjaneyulu M, Tirkey N, Chopra K. Attenuation of cyclosporine‐induced renal dysfunction by catechin: possible antioxidant mechanism. Ren Fail 2003;25:691–707. [DOI] [PubMed] [Google Scholar]
  • 26. Koca R, Armutcu F, Altinyazar C, Gurel C. A evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata. Med Sci Monit 2005;11:296–299. [PubMed] [Google Scholar]
  • 27. Demirbilek S, Ersoy MO, Demirbilek S, et al. Effects of polyenylphosphatidylcholine on cytokines, nitrite/nitrate levels, antioxidant activity and lipid peroxidation in rats with sepsis. Intensive Care Med 2004;30:1974–1978. [DOI] [PubMed] [Google Scholar]
  • 28. Parra Cid T, Garcia Conejo JR, Carballo Alvarez F, de Arriba G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology 2003;198:99–111. [DOI] [PubMed] [Google Scholar]
  • 29. Ichimura Y, Habuchi T, Tsuchiya N, et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol 2004;172:728–732. [DOI] [PubMed] [Google Scholar]
  • 30. Cengiz M, Ozaydin A, Ozkilic AC, Dedekarginoglu G. The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol 2007;39;1043–1048. [DOI] [PubMed] [Google Scholar]
  • 31. Salim EI, Morimura K, Menesi A, El‐Lity M, Fukushima S, Wanibuchi H. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer 2008;123:601–608. [DOI] [PubMed] [Google Scholar]
  • 32. Guven M, Ozturk B, Sayal A, Ozeturk A, Ulutin T. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis. Cancer Biochem Biophys 1999;17:155–162. [PubMed] [Google Scholar]
  • 33. Pavlova EL, Lilova MI, Savov VM. Oxidative stress in children with kidney disease. Pediatr Nephrol 2005;7:60–66. [DOI] [PubMed] [Google Scholar]
  • 34. Kaczmarek P, Buczyñski A, Niemirowicz J, Gnitecki W, Kocur E, Karpiñski J. Lipids peroxidation in platelets in patients with bladder cancer treated with Mycobacterium suspension. Pol Merkur Lekarski 2001;11:484–486. [PubMed] [Google Scholar]
  • 35. Castello T, Girona L, Gomez MR, Mena Mur A, Garcia L. The possible value of ascorbic acid as a prophylactic agent for urinary tract infection. Spinal Cord 1996;34:592–593. [DOI] [PubMed] [Google Scholar]
  • 36. Marquardt H, Bartolmas E, Nagel R. Results of drug‐induced acidification of the urine in 103 patients with urinary infection and‐or urolithiasis. Urologe 1973;12:173–176. [PubMed] [Google Scholar]
  • 37. Korenaga D, Takesue F, Kido K, et al. Impaired antioxidant defense system of colonic tissue and cancer development in dextran sulfate sodium‐induced colitis in mice. J Surg Res 2002;102:144–149. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES